Immunomodulation With Eltrombopag in ITP

Clinical trial NCT04812483 · COMPLETED

Trial details

NCT number: NCT04812483
Sponsor: University Children's Hospital Basel
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Primary Immune Thrombocytopenia (ITP)

Start date: 2022-09-01
Primary completion: 2024-04-11
Enrollment: 2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.